Ke Gu

633 total citations
48 papers, 471 citations indexed

About

Ke Gu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ke Gu has authored 48 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ke Gu's work include Endometrial and Cervical Cancer Treatments (8 papers), Ferroptosis and cancer prognosis (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Ke Gu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ferroptosis and cancer prognosis (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Ke Gu collaborates with scholars based in China, Germany and United States. Ke Gu's co-authors include Yanjun Zhou, Chao Xu, Shengjun Ji, Ningyi Ma, Jiandong Zhao, Guoliang Jiang, Songtao Lai, Yong Wen, Guo-Liang Jiang and Lu-Ming Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Ke Gu

44 papers receiving 459 citations

Peers

Ke Gu

HEPAT

ONCOL

PRM

Meng Guo China

Tixiao Wang China

Yutaka Sunose Japan

Yusuke Kumamoto Japan

Chad Wiesenauer United States

Guandou Yuan China

Tasuku Nakabori Japan

Cunzao Wu China

Lianyue Guan China

Keiichi Yoshimoto Japan

Meng Guo China

Ke Gu

315 ×2.1

67 ×0.6

HEPAT

107 ×1.2

ONCOL

47 ×0.6

PRM

156 ×2.1

Citations per year, relative to Ke Gu Ke Gu (= 1×) peers Meng Guo

Countries citing papers authored by Ke Gu

Since Specialization

Citations

This map shows the geographic impact of Ke Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Gu more than expected).

Fields of papers citing papers by Ke Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Gu. The network helps show where Ke Gu may publish in the future.

Co-authorship network of co-authors of Ke Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Gu. A scholar is included among the top collaborators of Ke Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Gu. Ke Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Peipei, et al.. (2025). Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy. Advanced Science. 13(2). e10854–e10854.

Zhu, Jianguo, et al.. (2025). Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter study. npj Precision Oncology. 9(1). 248–248. 1 indexed citations

Ji, Shengjun, et al.. (2024). Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy. SHILAP Revista de lepidopterología. 25(5). 986–999. 2 indexed citations

Zhou, Yanjun, et al.. (2024). Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma. Scientific Reports. 14(1). 3901–3901. 4 indexed citations

Gu, Ke, et al.. (2024). Yes-associated protein-mediated melatonin regulates the function of periodontal ligament stem cells under oxidative stress conditions. World Journal of Stem Cells. 16(11). 926–943. 2 indexed citations

Shen, Peipei, et al.. (2024). Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer. SHILAP Revista de lepidopterología. 25(5). 1000–1008. 4 indexed citations

Gu, Ke, et al.. (2023). Flavonoid intake is associated with lower all-cause and disease-specific mortality: The National Health and Nutrition Examination Survey 2007–2010 and 2017–2018. Frontiers in Nutrition. 10. 1046998–1046998. 7 indexed citations

Zhou, Yanjun, et al.. (2023). Inverse association between isoflavones and prediabetes risk: evidence from NHANES 2007–2010 and 2017–2018. Frontiers in Nutrition. 10. 1288416–1288416. 5 indexed citations

Zhou, Yanjun, et al.. (2023). Dietary Flavonoid Intake and Cancer Mortality: A Population-Based Cohort Study. Nutrients. 15(4). 976–976. 21 indexed citations

10.

Zhou, Yanjun, et al.. (2023). The associations between dietary flavonoid intake and the prevalence of diabetes mellitus: Data from the National Health and Nutrition Examination Survey 2007-2010 and 2017-2018. Frontiers in Endocrinology. 14. 1250410–1250410. 6 indexed citations

11.

Gu, Ke, et al.. (2022). Correlation between Ferroptosis-Related Gene Signature and Immune Landscape, Prognosis in Breast Cancer. Journal of Immunology Research. 2022. 1–19. 5 indexed citations

12.

Zhu, Jiahao, Gang Wu, Bo Ram Yang, et al.. (2022). Epidemiology, Treatment and Prognosis Analysis of Small Cell Breast Carcinoma: A Population-Based Study. Frontiers in Endocrinology. 13. 802339–802339. 5 indexed citations

13.

Wu, Gang, et al.. (2022). Ferroptosis‐Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2022(1). 7465880–7465880. 12 indexed citations

14.

Zhu, Jiahao, et al.. (2022). Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival. International Journal of General Medicine. Volume 15. 4959–4974. 12 indexed citations

15.

Gu, Ke, et al.. (2019). Small cell carcinoma of the uterine cervix with cerebellar metastasis: A special case report with literature review. Iranian Journal of radiation research. 17(2). 345–353.

16.

Ji, Shengjun, et al.. (2018). Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis. Cancer Management and Research. Volume 10. 1975–1985. 4 indexed citations

17.

Xu, Chao, et al.. (2016). Efficacy and Safety of Celecoxib Therapy in Osteoarthritis. Medicine. 95(20). e3585–e3585. 32 indexed citations

18.

Gu, Ke, et al.. (2015). Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis. Medicine. 94(26). e1007–e1007. 7 indexed citations

19.

Wang, Baoguo, et al.. (2013). Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures. Clinics. 68(3). 323–328. 12 indexed citations

20.

Gu, Ke, et al.. (2010). Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy Combined With Transcatheter Arterial Chemoembolization for Locally Advanced Hepatocellular Carcinoma: An Irradiation Dose Escalation Study. International Journal of Radiation Oncology*Biology*Physics. 79(2). 496–502. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact